Get access to our best features
Get access to our best features
Published 1 month ago

Genetics linked to rare blood clots from J&J and AstraZeneca Covid vaccines, researchers claim

  • Researchers found that rare blood clots linked to Johnson & Johnson and AstraZeneca Covid-19 vaccines result from an autoimmune reaction some people are predisposed to.
  • Adenovirus-Based vaccines, like J&J and AstraZeneca, contain a clot-triggering component for genetically susceptible individuals, impacting vaccine development.
  • With 60 cases in over 18 million J&J vaccine recipients and 2-3 cases per 100,000 AstraZeneca shots under 60 in Australia, clot-related deaths occurred.
Insights by Ground AI
Does this summary seem wrong?

0 Articles

All
Left
Center
Right
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 57% of the sources lean Right
50% Right
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)